Tuesday, March 8, 2016
2:45 – 4:00pm
From Novel Science to Clinical Development: Stories from Small Biotechs
- Jeremy P. Goldberg, Advisor, Torreya Partners
- Armand Girard, MBA, VP, Corporate Development, GlycoMimetics, Inc.
- Gayle M. Mills, MBA, Chief Business Officer, Symphogen
- Briggs Morrison, MD, Chief Executive Officer, Syndax Pharmaceuticals, Inc.
- Gisela M. Schwab, MD, President, Product Development & Medical Affairs and Chief Medical Officer, Exelixis, Inc.
- Christian Zahnd, PhD, Chief Executive Officer, Molecular Partners